Found: 34
Select item for more details and to access through your institution.
Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib.
- Published in:
- International Journal of Hematology, 2013, v. 98, n. 1, p. 66, doi. 10.1007/s12185-013-1367-z
- By:
- Publication type:
- Article
Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma.
- Published in:
- International Journal of Hematology, 2013, v. 97, n. 6, p. 743, doi. 10.1007/s12185-013-1321-0
- By:
- Publication type:
- Article
Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Transient inflammatory reaction during lenalidomide plus reduced-dose dexamethasone therapy in two patients with relapsed multiple myeloma.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myeloma.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Therapy with bortezomib plus dexamethasone induces osteoblast activation in responsive patients with multiple myeloma.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Correlation between high serum alkaline phosphatase levels and denosumab‐related hypocalcemia in patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 2, p. 355, doi. 10.1111/bjh.15837
- By:
- Publication type:
- Article
Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon‐α and ATRA.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 969, doi. 10.1111/bjh.15673
- By:
- Publication type:
- Article
Pim‐2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 4, p. 581, doi. 10.1111/bjh.14388
- By:
- Publication type:
- Article
Unique anti‐myeloma activity by thiazolidine‐2,4‐dione compounds with Pim inhibiting activity.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 2, p. 246, doi. 10.1111/bjh.15033
- By:
- Publication type:
- Article
Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0083905
- By:
- Publication type:
- Article
Inhibition of TACE Activity Enhances the Susceptibility of Myeloma Cells to TRAIL.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031594
- By:
- Publication type:
- Article
Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027222
- By:
- Publication type:
- Article
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 929, doi. 10.3390/cancers12040929
- By:
- Publication type:
- Article
Polyclonal Immunoglobulin Recovery after Autologous Stem Cell Transplantation Is an Independent Prognostic Factor for Survival Outcome in Patients with Multiple Myeloma.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 12, doi. 10.3390/cancers12010012
- By:
- Publication type:
- Article
Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central nervous system involvement.
- Published in:
- Journal of Medical Investigation, 2021, v. 68, n. 1/2, p. 196, doi. 10.2152/jmi.68.196
- By:
- Publication type:
- Article
The ADVIA2120i parameter Revised %MICRO is a surrogate marker of schistocyte formation after hematopoietic stem cell transplantation.
- Published in:
- Journal of Medical Investigation, 2020, v. 67, n. 3/4, p. 250, doi. 10.2152/jmi.67.250
- By:
- Publication type:
- Article
P-023: Assessment of liver stiffness with shear wave elastography for hepatic AL amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S52, doi. 10.1016/S2152-2650(21)02157-1
- By:
- Publication type:
- Article
P-005: Novel strategy of elotuzumab and zoledronic acid with Th1-like γδT cells against myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S41, doi. 10.1016/S2152-2650(21)02139-X
- By:
- Publication type:
- Article
Polyclonal immunoglobulin recovery after autologous stem cell transplantation is an independent prognosis factor for survival in patients with multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e215, doi. 10.1016/j.clml.2019.09.358
- By:
- Publication type:
- Article
Synergistic targeting of Sp1 in myeloma cells with hyperthermia plus proteasome inhibitors.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e132, doi. 10.1016/j.clml.2019.09.219
- By:
- Publication type:
- Article
Targeting myeloma metabolisms regulated by HDAC1-IRF4 axis can be a novel therapeutic strategy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e105, doi. 10.1016/j.clml.2019.09.173
- By:
- Publication type:
- Article
Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Comparison and Analysis of Delirium Induced by Histamine H<sub>2</sub> Receptor Antagonists and Proton Pump Inhibitors in Cancer Patients.
- Published in:
- Case Reports in Oncology, 2012, v. 5, n. 2, p. 409, doi. 10.1159/000341873
- By:
- Publication type:
- Article
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 6, p. 626, doi. 10.1007/s12185-024-03763-7
- By:
- Publication type:
- Article
Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 3, p. 291, doi. 10.1007/s12185-023-03706-8
- By:
- Publication type:
- Article
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 3, p. 303, doi. 10.1007/s12185-023-03705-9
- By:
- Publication type:
- Article
Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan.
- Published in:
- 2020
- By:
- Publication type:
- journal article
KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclasts.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 3, p. 328, doi. 10.1111/j.1365-2141.2011.08844.x
- By:
- Publication type:
- Article
Cryptosporidiosis in a transplant recipient with severe intractable diarrhea: Detection of <italic>Cryptosporidium</italic> oocysts by intestinal biopsies.
- Published in:
- Transplant Infectious Disease, 2018, v. 20, n. 2, p. 1, doi. 10.1111/tid.12826
- By:
- Publication type:
- Article
Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate.
- Published in:
- Journal of Bioenergetics & Biomembranes, 2012, v. 44, n. 1, p. 31, doi. 10.1007/s10863-012-9412-9
- By:
- Publication type:
- Article
Therapeutic efficacy of the resorcylic acid lactone LL‐Z1640‐2 for adult T‐cell leukaemia/lymphoma.
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 667, doi. 10.1002/jha2.758
- By:
- Publication type:
- Article
The importance of retaining physical functions to prevent skeletal‐related events in multiple myeloma patients with bone disease.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 480, doi. 10.1002/jha2.402
- By:
- Publication type:
- Article